MDNAF
Medicenna Therapeutics Corp.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 5/14/2024 | View on SEC |
| D | 5/14/2024 | View on SEC |
| EFFECT | 5/13/2024 | View on SEC |
| 6-K | 5/13/2024 | View on SEC |
| SC 13G | 5/10/2024 | View on SEC |
| POS AM | 5/10/2024 | View on SEC |
| 6-K | 4/30/2024 | View on SEC |
| 6-K | 4/26/2024 | View on SEC |
| 6-K | 4/25/2024 | View on SEC |
| AW | 4/22/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MDNAF |
| Company Name | Medicenna Therapeutics Corp. |
| CIK | 1807983 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 0331 |
| State of Incorporation | Z4 |
| Phone | 416 648-5555 |